These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 15353497

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
    Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG.
    Eur Heart J; 1997 Jan; 18(1):41-51. PubMed ID: 9049514
    [Abstract] [Full Text] [Related]

  • 3. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E, HOPE Investigators.
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
    [Abstract] [Full Text] [Related]

  • 4. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES).
    Kjøller-Hansen L, Steffensen R, Grande P.
    Am Heart J; 2004 Sep; 148(3):475-80. PubMed ID: 15389235
    [Abstract] [Full Text] [Related]

  • 5. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P.
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [Abstract] [Full Text] [Related]

  • 8. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
    Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA, Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators.
    N Engl J Med; 2005 Jun 23; 352(25):2581-8. PubMed ID: 15972864
    [Abstract] [Full Text] [Related]

  • 9. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
    Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC.
    N Engl J Med; 1995 Dec 21; 333(25):1670-6. PubMed ID: 7477219
    [Abstract] [Full Text] [Related]

  • 10. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Bertrand ME, Remme WJ, Fox KM, Ferrari R, Simoons ML, EUROPA investigators.
    Int J Cardiol; 2007 Sep 14; 121(1):57-61. PubMed ID: 17270296
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
    Bosch J, Lonn E, Pogue J, Arnold JM, Dagenais GR, Yusuf S, HOPE/HOPE-TOO Study Investigators.
    Circulation; 2005 Aug 30; 112(9):1339-46. PubMed ID: 16129815
    [Abstract] [Full Text] [Related]

  • 12. Why were the results of the Heart Outcomes Prevention Evaluation (HOPE) trial so astounding?
    Mancini GB, Stewart DJ.
    Can J Cardiol; 2001 May 30; 17 Suppl A():15A-7A. PubMed ID: 11381289
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?
    Boos CJ.
    Med Sci Monit; 2004 Dec 30; 10(12):SR23-8. PubMed ID: 15567997
    [Abstract] [Full Text] [Related]

  • 14. The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.
    Can J Cardiol; 1996 Feb 30; 12(2):127-37. PubMed ID: 8605634
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
    Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F.
    Circulation; 2006 Dec 19; 114(25):2766-72. PubMed ID: 17159063
    [Abstract] [Full Text] [Related]

  • 17. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.
    Gerstein HC.
    Diabetes Metab Res Rev; 2002 Dec 19; 18 Suppl 3():S82-5. PubMed ID: 12324991
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N, Cucherat M, Thuillez C, Durand E, Kadri Z, Steg PG.
    Arch Intern Med; 2006 Apr 10; 166(7):787-96. PubMed ID: 16606817
    [Abstract] [Full Text] [Related]

  • 19. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
    Rouleau JL, Warnica WJ, Baillot R, Block PJ, Chocron S, Johnstone D, Myers MG, Calciu CD, Dalle-Ave S, Martineau P, Mormont C, van Gilst WH, IMAGINE (Ischemia Management with Accupril post-bypass Graft via Inhibition of the coNverting Enzyme) Investigators.
    Circulation; 2008 Jan 01; 117(1):24-31. PubMed ID: 18071079
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.